Clinical trial · Interventional
Multiple Myeloma and Exercise
Modulating The Toxicity And Efficacy Of High Dose Chemotherapy For Multiple Myeloma Through An Intervention To Increase Lean Body Mass
NCT01809717CI-TRIAL-00043930completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will establich the feasibility of weight lifting exercise among patients with multiple myeloma, determine if weight lifting exercise increases lean body mass among patients with multiple myeloma and obtain further preliminary data on toxicity and pharmacokinetics of high-dose melphalan.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Newly Diagnosed Multiple Myeloma | Multiple Myeloma | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Weight Lifting Exercises | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Weight Lifting Exercises
- interventionNames
- Other: Weight Lifting Exercises
Primary outcomes (1)
- measure
- Number of Adverse Events
- timeFrame
- 3-6 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically confirmed multiple myeloma * 1 year since start of treatment for myeloma * Patient and treating physician in agreement to proceed with autologous transplant, with a planned time betwwen study enrollment and transplant of 10 weeks * Age 18 years. * Able to walk for 6 minutes unaided. * Body mass index 50 kg/m2 * Serum creatinine 2.5 mg/dL * Ability to understand the informed consent document and willingness to consent. Written informed consent must be obtained from all patients before study entry. Exclusion Criteria: * Recent (in the past 6 months) participation in progressive weight lifting exercises or who already exercise regulary (3 times a week of moderate intensity aerobic exercise). * Plan to move out of the area during the study intervention. * A psychological, social, or logistical barrier that the principal investigators feel would preclude completion of the study protocol. * Plan for use of any anti-myeloma treatment other than melphalan (the use of total body irradiation will NOT
References
Publications (0)
Data not yet available
No reference posted for this study.